AAV-based delivery of RNAi targeting ataxin-2 improves survival and pathology in TDP-43 mice.
Amado DA, Robbins AB, Whiteman KR, Smith AR, Chillon G, Chen Y, Fuller JA, Patty NA, Izda A, Cheng C, Nelson S, Dichter AI, Mazzoni EO, Monteys AM, Davidson BL.
Amado DA, et al. Among authors: robbins ab.
Nat Commun. 2025 Jun 25;16(1):5334. doi: 10.1038/s41467-025-60497-8.
Nat Commun. 2025.
PMID: 40562771
Free PMC article.